ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $61,968,061 | +31.9% | 14,932,063 | +52.8% | 1.22% | +37.5% |
Q2 2023 | $46,997,418 | +18.5% | 9,770,773 | 0.0% | 0.89% | -1.2% |
Q1 2023 | $39,669,338 | -24.8% | 9,770,773 | 0.0% | 0.90% | -16.1% |
Q4 2022 | $52,762,174 | -46.2% | 9,770,773 | 0.0% | 1.07% | -48.8% |
Q3 2022 | $98,001,000 | +113.4% | 9,770,773 | 0.0% | 2.09% | +70.8% |
Q2 2022 | $45,923,000 | +20.2% | 9,770,773 | 0.0% | 1.22% | +46.8% |
Q1 2022 | $38,204,000 | -42.2% | 9,770,773 | 0.0% | 0.83% | -28.4% |
Q4 2021 | $66,050,000 | -54.5% | 9,770,773 | 0.0% | 1.16% | -42.1% |
Q3 2021 | $145,194,000 | – | 9,770,773 | – | 2.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sands Capital Ventures, LLC | 3,417,075 | $14,180,861 | 4.20% |
Knollwood Investment Advisory, LLC | 1,628,510 | $6,758,317 | 3.16% |
Altium Capital Management LP | 650,000 | $2,697,500 | 1.41% |
RA Capital Management | 14,932,063 | $61,968,061 | 1.22% |
GREAT POINT PARTNERS LLC | 1,074,101 | $4,457,519 | 0.81% |
Boxer Capital, LLC | 2,206,983 | $9,158,979 | 0.49% |
Deep Track Capital, LP | 2,513,044 | $10,429,133 | 0.40% |
Parkman Healthcare Partners LLC | 499,814 | $2,074,228 | 0.38% |
Rock Springs Capital Management LP | 2,812,579 | $11,672,203 | 0.31% |
Ghost Tree Capital, LLC | 150,000 | $622,500 | 0.20% |